PIPages
Labs

David W Piston

Washington University in St Louis, MO·Physiology

Cells constantly send chemical signals to one another and within themselves, both to keep blood sugar in check and to sound the alarm when something goes wrong. The research here spans two such signaling problems.

Fields

Physiology

Microbiology & Immunology

Biochemistry

Topics

diabetes

glucagon

pancreatic alpha cells

Grants
4 known grants, through Jan 2031

What they work on

  1. Identify which fragments of nidogen-2, a brown-fat-secreted protein, inhibit glucagon release from pancreatic alpha cells and which activate insulin receptors, building on reversal of diabetes in NOD mice.
  2. Determine the molecular target on pancreatic alpha cells through which nidogen-2 and its fragments suppress glucagon secretion.
  3. Determine how calcium released through the TRPV2 ion channel activates STING, a sensor of misplaced DNA, and test whether losing Trpv2 rescues Trex1-knockout mice that model Aicardi-Goutières syndrome.
  4. Define how TRPV2's physical binding to STING on the endoplasmic reticulum, and its relationship with the calcium-sensing protein STIM1, regulate STING activation.

More about the research

The first is how a protein released by brown fat could calm glucagon, a hormone that raises blood sugar. The second is how calcium released inside cells tunes an immune alarm system that detects stray DNA. Alongside these projects, the PI directs shared microscopy services for rheumatic disease researchers and a pilot grant program for diabetes researchers.

Why it matters

A treatment based on a fragment of nidogen-2 could be used with insulin to help people with type 1 and advanced type 2 diabetes keep blood sugar near normal with lower insulin doses and fewer hypoglycemic episodes. Understanding how TRPV2 and calcium control the STING immune alarm could point to new treatment strategies for autoimmune diseases such as Aicardi-Goutières syndrome, for chronic inflammation and for cancer.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Brown adipose tissue derived nidogen-2 as a diabetes therapeutic

NIH · Feb 2026 – Jan 2031

Dual Role of TRPV2 in the STING-mediated innate immune response

NIH · Jul 2025 – Jun 2029

Cellular Imaging Core

NIH · Sep 2018 – Aug 2028

Closest labs

Jonathan Campbell

Duke University, NC·Physiology

Test whether pericytes, cells lining blood vessels, are the main GIP receptor (GIPR)-expressing cells in fat tissue, using mouse models that mark and lineage-trace GIPR-positive cells over time.

Barak Blum

University of Wisconsin-Madison, WI·Physiology

Test the hypothesis that reducing Robo2 receptors in beta cells, the pancreas's insulin-making cells, is essential for islets of Langerhans to expand successfully when insulin demand rises.

David Aaron Jacobson

Vanderbilt University, TN·Physiology

Determine how the calcium pump PMCA1 and sodium/calcium exchanger NCX1 control β-cell calcium removal and insulin secretion, and how diabetes alters them, using β-cell knockout mice and human pseudoislets with shRNA knockdown.

The school

Washington University in St Louis: 97 labs on PI Pages, $1.2B a year on research, 365 research doctorates a year.

More about Washington University in St Louis

Reach out

A start for your email. Fill in the brackets.